Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Association of 1,25-dihydroxyvitamin D levels with physical performance and thigh muscle cross-sectional area in chronic kidney disease stage 3 and 4.

Gordon PL, Doyle JW, Johansen KL.

J Ren Nutr. 2012 Jul;22(4):423-33. doi: 10.1053/j.jrn.2011.10.006. Epub 2012 Jan 9.

2.

Glomerular filtration rate and parathyroid hormone are associated with 1,25-dihydroxyvitamin D in men without chronic kidney disease.

Karhapää P, Pihlajamäki J, Pörsti I, Kastarinen M, Mustonen J, Niemelä O, Tuomi H, Kuusisto J.

J Intern Med. 2012 Jun;271(6):573-80. doi: 10.1111/j.1365-2796.2011.02471.x. Epub 2011 Nov 15.

3.

Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD.

Al-Aly Z, Qazi RA, González EA, Zeringue A, Martin KJ.

Am J Kidney Dis. 2007 Jul;50(1):59-68.

PMID:
17591525
4.

Dietary vitamin D intake is not associated with 25-hydroxyvitamin D3 or parathyroid hormone in elderly subjects, whereas the calcium-to-phosphate ratio affects parathyroid hormone.

Jungert A, Neuhäuser-Berthold M.

Nutr Res. 2013 Aug;33(8):661-7. doi: 10.1016/j.nutres.2013.05.011. Epub 2013 Jun 28.

PMID:
23890356
5.

Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.

Tomida K, Hamano T, Mikami S, Fujii N, Okada N, Matsui I, Nagasawa Y, Moriyama T, Ito T, Imai E, Isaka Y, Rakugi H.

Bone. 2009 Apr;44(4):678-83. doi: 10.1016/j.bone.2008.11.016. Epub 2008 Dec 9.

PMID:
19111635
6.

Predictors of vitamin D status in predialysis chronic kidney disease patients: a cross-sectional analysis in a high ultraviolet climate.

Petchey WG, Johnson DW, Hawley CM, Isbel NM.

J Ren Nutr. 2012 Jul;22(4):400-8. doi: 10.1053/j.jrn.2011.08.007. Epub 2011 Nov 9.

PMID:
22074789
7.

Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.

Keyzer CA, Lambers-Heerspink HJ, Joosten MM, Deetman PE, Gansevoort RT, Navis G, Kema IP, de Zeeuw D, Bakker SJ, de Borst MH; PREVEND Study Group.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2119-27. doi: 10.2215/CJN.03830415. Epub 2015 Oct 8.

8.

Vitamin D status of chronic kidney disease patients living in a sunny country.

Cuppari L, Carvalho AB, Draibe SA.

J Ren Nutr. 2008 Sep;18(5):408-14. doi: 10.1053/j.jrn.2008.05.004.

PMID:
18721735
9.

Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.

Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.

Nephron Clin Pract. 2008;110(1):c58-65. doi: 10.1159/000151534. Epub 2008 Aug 25.

PMID:
18724068
10.

The relationship between the level of serum 25-hydroxyvitamin D and renal function in patients without chronic kidney disease: a cross-sectional study.

Tak YJ, Lee JG, Song SH, Kim YJ, Lee S, Jung DW, Yi YH, Cho YH, Choi EJ, Hwang HR.

J Ren Nutr. 2015 Mar;25(2):88-96. doi: 10.1053/j.jrn.2014.07.007. Epub 2014 Sep 17.

PMID:
25238696
11.

Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.

Blair D, Byham-Gray L, Lewis E, McCaffrey S.

J Ren Nutr. 2008 Jul;18(4):375-82. doi: 10.1053/j.jrn.2008.04.008. Erratum in: J Ren Nutr. 2009 Mar;19(2):195.

PMID:
18558303
12.

Comparisons of serum vitamin D levels, status, and determinants in populations with and without chronic kidney disease not requiring renal dialysis: a 24-hour urine collection population-based study.

Guessous I, McClellan W, Kleinbaum D, Vaccarino V, Zoller O, Theler JM, Paccaud F, Burnier M, Bochud M; Swiss Survey on Salt Group.

J Ren Nutr. 2014 Sep;24(5):303-12. doi: 10.1053/j.jrn.2014.04.005. Epub 2014 Jul 13.

PMID:
25030223
13.

Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.

Zisman AL, Hristova M, Ho LT, Sprague SM.

Am J Nephrol. 2007;27(1):36-43. Epub 2007 Jan 11.

PMID:
17215573
14.

Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study.

Zehnder D, Landray MJ, Wheeler DC, Fraser W, Blackwell L, Nuttall S, Hughes SV, Townend J, Ferro C, Baigent C, Hewison M.

Nephron Clin Pract. 2007;107(3):c109-16. Epub 2007 Sep 21.

PMID:
17890873
15.

Vitamin D status and its association with mineral and bone disorder in a multi-ethnic chronic kidney disease population.

Ngai M, Lin V, Wong HC, Vathsala A, How P.

Clin Nephrol. 2014 Oct;82(4):231-9. doi: 10.5414/CN108182.

PMID:
25161115
16.

Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23.

Mazzaferro S, Pasquali M, Pugliese F, Citterio F, Gargiulo A, Rotondi S, Tartaglione L, Conte C, Pirrò G, Taggi F.

J Nephrol. 2012 Nov-Dec;25(6):1108-18. doi: 10.5301/jn.5000102.

PMID:
22383345
17.

Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials.

de Boer IH, Sachs MC, Chonchol M, Himmelfarb J, Hoofnagle AN, Ix JH, Kremsdorf RA, Lin YS, Mehrotra R, Robinson-Cohen C, Siscovick DS, Steffes MW, Thummel KE, Tracy RP, Wang Z, Kestenbaum B.

Am J Kidney Dis. 2014 Aug;64(2):187-97. doi: 10.1053/j.ajkd.2014.02.015. Epub 2014 Apr 3.

18.

Genetic, Environmental, and Disease-Associated Correlates of Vitamin D Status in Children with CKD.

Doyon A, Schmiedchen B, Sander A, Bayazit A, Duzova A, Canpolat N, Thurn D, Azukaitis K, Anarat A, Bacchetta J, Mir S, Shroff R, Yilmaz E, Candan C, Kemper M, Fischbach M, Cortina G, Klaus G, Wuttke M, Köttgen A, Melk A, Querfeld U, Schaefer F; 4C Study Consortium.

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1145-53. doi: 10.2215/CJN.10210915. Epub 2016 Jun 16.

19.

Does serum 25-hydroxyvitamin D influence muscle development during puberty in girls? A 7-year longitudinal study.

Wang R, Alen M, Yu Z, Wiklund P, Cheng SM, Törmäkangas T, Chen P, Cheng S.

PLoS One. 2013 Dec 16;8(12):e82124. doi: 10.1371/journal.pone.0082124. eCollection 2013.

20.

Racial differences in markers of mineral metabolism in advanced chronic kidney disease.

Jovanovich A, Chonchol M, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Kendrick J; HOST Investigators.

Clin J Am Soc Nephrol. 2012 Apr;7(4):640-7. doi: 10.2215/CJN.07020711. Epub 2012 Mar 1.

Supplemental Content

Support Center